782 related articles for article (PubMed ID: 6379149)
1. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
Martin MW; Smith MM; Harden TK
J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
[TBL] [Abstract][Full Text] [Related]
2. Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors.
Harden TK; Meeker RB; Martin MW
J Pharmacol Exp Ther; 1983 Dec; 227(3):570-7. PubMed ID: 6317839
[TBL] [Abstract][Full Text] [Related]
3. Regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide.
Ehlert FJ; Roeske WR; Yamamura HI
J Supramol Struct; 1980; 14(2):149-62. PubMed ID: 7230804
[TBL] [Abstract][Full Text] [Related]
4. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
Baker SP; Posner P
Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
[TBL] [Abstract][Full Text] [Related]
5. Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.
Waelbroeck M; Robberecht P; Chatelain P; Christophe J
Mol Pharmacol; 1982 May; 21(3):581-8. PubMed ID: 7110116
[TBL] [Abstract][Full Text] [Related]
6. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
7. Differences in the properties of muscarinic cholinergic receptors in the developing chick myocardium.
Hosey MM; McMahon KK; Danckers AM; O'Callahan CM; Wong J; Green RD
J Pharmacol Exp Ther; 1985 Mar; 232(3):795-801. PubMed ID: 3973828
[TBL] [Abstract][Full Text] [Related]
8. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
[TBL] [Abstract][Full Text] [Related]
9. The biphasic response of muscarinic cholinergic receptors in cultured heart cells to agonists. Effects on receptor number and affinity in intact cells and homogenates.
Galper JB; Dziekan LC; O'Hara DS; Smith TW
J Biol Chem; 1982 Sep; 257(17):10344-56. PubMed ID: 7107608
[TBL] [Abstract][Full Text] [Related]
10. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
[TBL] [Abstract][Full Text] [Related]
11. MgCl2-sensitive and Gpp(NH)p-sensitive antagonist binding states of rat heart muscarinic receptors: preferential detection at ambient temperature assay and location in two subcellular fractions.
Sulakhe PV; Jagadeesh G; Phan NT; Rao TS; Veeranjaneyulu A
Mol Cell Biochem; 1990 May; 94(2):133-46. PubMed ID: 2374547
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
Dunlap J; Brown JH
Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
[TBL] [Abstract][Full Text] [Related]
14. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
15. Evidence of paired M2 muscarinic receptors.
Potter LT; Ballesteros LA; Bichajian LH; Ferrendelli CA; Fisher A; Hanchett HE; Zhang R
Mol Pharmacol; 1991 Feb; 39(2):211-21. PubMed ID: 1899905
[TBL] [Abstract][Full Text] [Related]
16. Agonist interactions with cardiac muscarinic receptors. Effects of Mg2+, guanine nucleotides, and monovalent cations.
McMahon KK; Hosey MM
Mol Pharmacol; 1985 Nov; 28(5):400-9. PubMed ID: 4058421
[TBL] [Abstract][Full Text] [Related]
17. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic receptors in porcine caudate nucleus. I. Enhancement by nickel and other cations of [3H]cis-methyldioxolane binding to guanyl nucleotide-sensitive sites.
Nukada T; Haga T; Ichiyama A
Mol Pharmacol; 1983 Nov; 24(3):366-73. PubMed ID: 6633503
[TBL] [Abstract][Full Text] [Related]
19. High affinity binding of [3H]acetylcholine to muscarinic receptors. Regional distribution and modulation by guanine nucleotides.
Gurwitz D; Kloog Y; Sokolovsky M
Mol Pharmacol; 1985 Sep; 28(3):297-305. PubMed ID: 4033630
[TBL] [Abstract][Full Text] [Related]
20. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
